Live Breaking News & Updates on Mathilde Bohin|Page 22
Stay updated with breaking news from Mathilde bohin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Implanet Confirms Offer to Acquire a Majority Stake in Orthopaedic & Spine Development Orthopaedic Spine Development ( OSD ) is a manufacturer of implants for spine surgery Acquisition of a majority interest will lead to the creation of a new benchmark player in orthopedic surgery in France and allow the Group to rapidly achieve significant revenue growth. Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it has obtained founding shareholders agreement to acquire a majority stake in Orthopaedic Spine Development ( OSD ), which specializes in developing, manufacturing and marketing implants for spine surgery. ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update Erytech Pharma S.A.March 4, 2021 GMT ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update Lyon (France) and Cambridge, MA (U.S.), March 4, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its fourth quarter and full year 2020 conference call and webcast on Tuesday, March 9, 2021, at 2:30 PM CET/8:30 AM ET to discuss operational highlights. ....
IMPLANET: Implanet Reports an Improvement in Its 2020 Results Gross margin improvement to 58.2%, versus 56% in 2019 Strengthened cash position Regulatory Nws: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, announces its results for the financial year to December 31, 2020, approved by the Board of Directors on February 16, 2021.
Within the very unique public health context that affected 2020, we generated over 6 million euros in revenue and continued to improve the gross margin , commented Implanet CEO Ludovic Lastennet. These results strengthen our confidence in our resiliency during a period during which surgical programs have been heavily disrupted by postponements or cancellations. Our external growth strategy, notably through the acquisition project announced in January, indicates our intention of ....
Implanet Announces 2020 Revenue of €6 Million Fourth quarter JAZZ sales up 9% compared with the fourth quarter of 2019, with 34% growth in the United States Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral and knee-surgery implants, today announced its provisional unaudited fourth-quarter revenue, annual revenue and cash position at December 31, 2020. Ludovic Lastennet, Implanet s Chief Executive Officer, commented: Although down versus prior year, our revenue totaled €6 million in 2020, illustrating our ability to remain resilient in a period heavily impacted by the public health crisis and the cancellation or postponement of surgical operations. In the fourth quarter, the decrease in Knee activity in France was partly offset by significant growth in JAZZ ....
THIS PRESS RELEASE SHOULD NOT BE PUBLISHED OR DISTRIBUTED, EITHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA This acquisition would allow the Company to ....